| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 185,800 | $1 | $743.2K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 55,460 | $10 | $554.6K |
| J3262 | Injection, tocilizumab, 1 mg | 99,870 | $10 | $499.4K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11,300 | $30 | $384.2K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 13,680 | $30 | $355.7K |
| J0897 | Injection, denosumab, 1 mg | 12,780 | $20 | $230K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 950 | $110 | $103.8K |
| 76881 | In this procedure, the provider uses ultrasound to examine the complete joint for any defect or abnormality. The image appears in real time on a monitor, and a permanent image with interpretation is… | 1,450 | $40 | $61K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 610 | $100 | $60K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 680 | $60 | $41.5K |